Search Results - "KNIGHT, BRADLEY P"

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator by Weiss, Raul, Knight, Bradley P., Gold, Michael R., Leon, Angel R., Herre, John M., Hood, Margaret, Rashtian, Mayer, Kremers, Mark, Crozier, Ian, Lee, Kerry L., Smith, Warren, Burke, Martin C.

“…BACKGROUND—The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous…”
Get full text

On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial by Upadhyay, Gaurav A., Vijayaraman, Pugazhendhi, Nayak, Hemal M., Verma, Nishant, Dandamudi, Gopi, Sharma, Parikshit S., Saleem, Moeen, Mandrola, John, Genovese, Davide, Oren, Jess W., Subzposh, Faiz A., Aziz, Zaid, Beaser, Andrew, Shatz, Dalise, Besser, Stephanie, Lang, Roberto M., Trohman, Richard G., Knight, Bradley P., Tung, Roderick

“…The His-SYNC pilot trial was the first randomized comparison between His bundle pacing in lieu of a left ventricular lead for cardiac resynchronization therapy…”
Get full text

Head-To-Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study by GOLD, MICHAEL R., THEUNS, DOMINIC A., KNIGHT, BRADLEY P., STURDIVANT, J. LACY, SANGHERA, RICK, ELLENBOGEN, KENNETH A., WOOD, MARK A., BURKE, MARTIN C.

“…Arrhythmia Detection with S‐ICD Versus Transvenous ICDs. Background: The development of a totally subcutaneous implantable defibrillator (S‐ICD) system…”
Get full text

Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results by Gold, Michael R., Aasbo, Johan D., El-Chami, Mikhael F., Niebauer, Mark, Herre, John, Prutkin, Jordan M., Knight, Bradley P., Kutalek, Steven, Hsu, Kevin, Weiss, Raul, Bass, Eric, Husby, Michael, Stivland, Timothy M., Burke, Martin C.

“…The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to reduce short- and long-term complications associated with transvenous ICD…”
Get full text

Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts by Lambiase, Pier D., PhD, FHRS, FRCP, Gold, Michael R., MD, PhD, Hood, Margaret, MB, Boersma, Lucas, MD, PhD, Theuns, Dominic A.M.J., PhD, Burke, Martin C., DO, Weiss, Raul, MD, Russo, Andrea M., MD, Kääb, Stefan, MD, PhD, Knight, Bradley P., MD

“…Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a potential alternative to transvenous systems in hypertrophic cardiomyopathy…”
Get full text

The extravascular implantable cardioverter‐defibrillator: The pivotal study plan by Crozier, Ian, O'Donnell, David, Boersma, Lucas, Murgatroyd, Francis, Manlucu, Jaimie, Knight, Bradley P., Birgersdotter‐Green, Ulrika Maria, Leclercq, Christophe, Thompson, Amy, Sawchuk, Robert, Willey, Sarah, Wiggenhorn, Christopher, Friedman, Paul

“…Background Transvenous implantable cardioverter defibrillators (TV ICD) provide life‐saving therapy for millions of patients worldwide. However, they are…”
Get full text

Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator by Groh, Christopher A., MD, Sharma, Shishir, MD, Pelchovitz, Daniel J., MD, Bhave, Prashant D., MD, Rhyner, John, MD, Verma, Nishant, MD, Arora, Rishi, MD, Chicos, Alexandru B., MD, Kim, Susan S., MD, Lin, Albert C., MD, Passman, Rod S., MD, FHRS, Knight, Bradley P., MD, FHRS

“…Background An electrocardiographic (ECG) screening test has been developed to identify patients being considered for a totally subcutaneous implantable…”
Get full text

Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay by Liu, Albert Y., Charron, Jessica, Fugaro, Dana, Spoolstra, Scott, Kaplan, Rachel, Lohrmann, Graham, Gao, Xu, Gay, Hawkins, Passman, Rod, Kim, Susan, Lin, Albert C., Chicos, Alexandru, Arora, Rishi, Patil, Kaustubha, Pfenniger, Anna, Knight, Bradley P., Verma, Nishant

“…Introduction Oral sotalol initiation requires a multiple‐day, inpatient admission to monitor for QT prolongation during loading. A 1‐day intravenous (IV)…”
Get full text

Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients by Hoster, Clay, Rahman, Annas, Goyal, Ansh, Peigh, Graham, Trohman, Richard, Knight, Bradley P, Huang, Henry, Krishnan, Kousik, Larsen, Timothy, Mazur, Alexander, Sharma, Parikshit, Engelstein, Erica, Verma, Nishant, Wasserlauf, Jeremiah

“…Subcutaneous implantable cardioverter-defibrillators (S-ICD) are an alternative to transvenous ICDs for patients without a need for cardiac pacing. Obese…”
Get full text

Update in Cardiac Pacing by Verma, Nishant, Knight, Bradley P

“…Initial efforts to artificially stimulate the heart were borne out of a necessity to prevent catastrophic bradycardic events. The initial pacemaker systems…”
Get full text

Bronchial effects of cryoballoon ablation for atrial fibrillation by Verma, Nishant, MD, MPH, Gillespie, Colin T., MD, Argento, A. Christine, MD, Tomson, Todd, MD, Dandamudi, Sanjay, MD, Piña, Paloma, MD, Ringwala, Sukit, MD, Lin, Albert C., MD, Chicos, Alexandru B., MD, Kim, Susan, MD, Arora, Rishi, MD, Passman, Rod S., MD, MSCE, FHRS, Knight, Bradley P., MD, FHRS

“…Background Damage to extracardiac structures, including the esophagus and phrenic nerve, is a known complication of cryoballoon ablation (CBA) during pulmonary…”
Get full text

Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series by Peigh, Graham, Leya, Marysa V, Baman, Jayson R, Cantey, Eric P, Knight, Bradley P, Flaherty, James D

“…Abstract Background Novel coronavirus-19 disease (COVID-19) is associated with significant cardiovascular morbidity and mortality. To date, there have not been…”
Get full text

Conduction recovery following pacemaker implantation after transcatheter aortic valve replacement by Kaplan, Rachel M., Yadlapati, Ajay, Cantey, Eric P., Passman, Rod S., Gajjar, Mark, Knight, Bradley P., Sweis, Ranya, Ricciardi, Mark J., Pham, Duc T., Churyla, Andrei, Malaisrie, S. Chris, Davidson, Charles J., Flaherty, James D.

“…Background Transcatheter aortic valve replacement (TAVR) is increasingly used to treat severe aortic stenosis. A frequent complication of TAVR is high‐grade or…”
Get full text

Sex Differences in Ablation Strategy, Lesion Sets, and Complications of Catheter Ablation for Atrial Fibrillation: An Analysis From the GWTG-AFIB Registry by Yunus, Fahd N., Perino, Alexander C., Holmes, DaJuanicia N., Matsouaka, Roland A., Curtis, Anne B., Ellenbogen, Kenneth A., Frankel, David S., Knight, Bradley P., Russo, Andrea M., Lewis, William R., Piccini, Jonathan P., Turakhia, Mintu P.

“…When presenting for atrial fibrillation (AF) ablation, women, compared with men, tend to have more nonpulmonary vein triggers and advanced atrial disease…”
Get full text

The Use of Intracardiac Echocardiography and Other Intracardiac Imaging Tools to Guide Noncoronary Cardiac Interventions by Kim, Susan S., MD, Hijazi, Ziyad M., MD, Lang, Roberto M., MD, Knight, Bradley P., MD

“…The limitations of standard fluoroscopy have led to the development of improved imaging techniques to guide noncoronary cardiac interventions. Imaging tools…”
Get full text

Electrogram morphology recurrence patterns during atrial fibrillation by Ng, Jason, PhD, Gordon, David, MD, PhD, Passman, Rod S., MD, FHRS, Knight, Bradley P., MD, FHRS, Arora, Rishi, MD, FHRS, Goldberger, Jeffrey J., MD, FHRS

“…Background Traditional mapping of atrial fibrillation (AF) is limited by changing electrogram morphologies and variable cycle lengths. Objective We tested the…”
Get full text

Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling: A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation by Rottmann, Markus, Yoo, Shin, Pfenniger, Anna, Mikhailov, Aleksei, Benefield, Brandon, Johnson, David A, Zhang, Wenwei, Ghosh, Asish K, Kim, Daniel, Passman, Rod, Knight, Bradley P, Lee, Daniel C, Arora, Rishi

“…The temporal progression states of the molecular and structural substrate in atrial fibrillation (AF) are not well understood. We hypothesized that these can…”
Get full text

Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator by Gold, Michael R., MD, PhD, FHRS, Weiss, Raul, MD, FHRS, Theuns, Dominic A.M.J., PhD, Smith, Warren, MD, Leon, Angel, MD, Knight, Bradley P., MD, FHRS, Carter, Nathan, MS, Husby, Michael, MS, MPH, Burke, Martin C., DO

“…Background The subcutaneous implantable cardioverter-defibrillator system (S-ICD) uses a novel detection algorithm previously shown to discriminate induced…”
Get full text

Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation by ORAL, Hakan, KNIGHT, Bradley P, STRICKBERGER, S. Adam, MORADY, Fred, TADA, Hiroshi, ÖZAYDIN, Mehmet, CHUGH, Aman, HASSAN, Sohail, SCHARF, Christoph, LAI, Steve W. K, GREENSTEIN, Radmira, JR, Frank Pelosi

“…The pulmonary veins (PVs) have been demonstrated to often play an important role in generating atrial fibrillation (AF). The purpose of this study was to…”
Get full text

The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices by Dandamudi, Sanjay, MD, Collins, Jeremy D., MD, Carr, James C., MD, Mongkolwat, Pat, PhD, Rahsepar, Amir A., MD, Tomson, Todd T., MD, Verma, Nishant, MD, Arora, Rishi, MD, Chicos, Alex B., MD, Kim, Susan S., MD, Lin, Albert C., MD, Passman, Rod S., MD, Knight, Bradley P., MD

“…Rationale and Objectives Studies reporting the safety of magnetic resonance imaging (MRI) in patients with a cardiac implantable electronic device (CIED) have…”
Get full text